Nvidia Most Active Stock in S&P 500 and Nasdaq 100 So Far Today — Data Talk
NVIDIA Corporation (NVDA) is currently at $121.24, down $4.36 or 3.48%
--Would be lowest close since Aug. 14, 2024, when it closed at $118.08
--Currently down three of the past four days
--Currently down two consecutive days; down 5.5% over this period
--Worst two day stretch since the two days ending Aug. 5, 2024, when it fell 8.02%
--Up 3.61% month-to-date; on pace for best month since June 2024, when it rose 12.69%
--Up 144.83% year-to-date
--Down 10.57% from its all-time closing high of $135.58 on June 18, 2024
--Up 145.66% from 52 weeks ago (Aug. 31, 2023), when it closed at $49.36
--Down 10.57% from its 52-week closing high of $135.58 on June 18, 2024
--Up 200.66% from its 52-week closing low of $40.33 on Oct. 26, 2023
--Traded as low as $119.23; lowest intraday level since Aug. 15, 2024, when it hit $117.47
--Down 5.08% at today's intraday low; largest intraday percent decrease since Aug. 7, 2024, when it fell as much as 5.33%
--Fourth worst performer in the S&P 500 today
--Most active stock in the S&P 500 today
--Second worst performer in the Nasdaq 100 today
--Most active stock in the Nasdaq 100 today
All data as of 11:38:16 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 29, 2024 11:56 ET (15:56 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk